ValiRx plc (LON:VAL – Get Free Report) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 0.26 and traded as low as GBX 0.14. ValiRx shares last traded at GBX 0.14, with a volume of 4,121,096 shares.
ValiRx Trading Up 6.7%
The company has a 50 day simple moving average of GBX 0.17 and a 200 day simple moving average of GBX 0.26. The stock has a market capitalization of £2.11 million, a PE ratio of -0.30 and a beta of 0.59. The company has a current ratio of 4.62, a quick ratio of 1.27 and a debt-to-equity ratio of 0.05.
ValiRx (LON:VAL – Get Free Report) last released its earnings results on Monday, June 22nd. The company reported GBX (0.54) earnings per share (EPS) for the quarter. The company had revenue of GBX 3 million during the quarter. ValiRx had a negative net margin of 7,115.36% and a negative return on equity of 70.79%. Analysts predict that ValiRx plc will post -1.74 earnings per share for the current fiscal year.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Further Reading
- Five stocks we like better than ValiRx
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
